{"success":true,"data":{"pressRelease":{"id":"12028","rtpr_id":"nACSBhwhja","ticker":"RGC","exchange":"NASDAQ","all_tickers":["RGC"],"title":"ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGC","author":"ACCESSWIRE","published_at":"2026-04-29T01:23:00.980Z","article_body":"NEW YORK, NY / ACCESS Newswire (https://www.accessnewswire.com/) / April 28,\n2026 / The Rosen Law Firm, P.A.\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces a class\naction lawsuit on behalf of purchasers of securities of Regencell Bioscience\nHoldings Limited (NASDAQ:RGC) between October 28, 2024 and October 31, 2025,\ninclusive (the \"Class Period\"). A class action lawsuit has already been filed.\nIf you wish to serve as lead plaintiff, you must move the Court no later than\nJune 23, 2026.\n\nSO WHAT: If you purchased Regencell securities during the Class Period you may\nbe entitled to compensation without payment of any out of pocket fees or costs\nthrough a contingency fee arrangement.\n\nWHAT TO DO NEXT: To join the Regencell class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=62621 or call Phillip Kim, Esq.\ntoll-free at 866-767-3653 or email case@rosenlegal.com for information on the\nclass action. A class action lawsuit has already been filed. If you wish to\nserve as lead plaintiff, you must move the Court no later than June 23, 2026.\nA lead plaintiff is a representative party acting on behalf of other class\nmembers in directing the litigation.\n\nWHY ROSEN LAW: We encourage investors to select qualified counsel with a track\nrecord of success in leadership roles. Often, firms issuing notices do not\nhave comparable experience, resources, or any meaningful peer recognition. Be\nwise in selecting counsel. The Rosen Law Firm represents investors throughout\nthe globe, concentrating its practice in securities class actions and\nshareholder derivative litigation. Rosen Law Firm has achieved, at that time,\nthe largest ever securities class action settlement against a Chinese Company.\nRosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for\nnumber of securities class action settlements in 2017. The firm has been\nranked in the top 4 each year since 2013 and has recovered hundreds of\nmillions of dollars for investors. In 2019 alone the firm secured over $438\nmillion for investors. In 2020, founding partner Laurence Rosen was named by\nlaw360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been\nrecognized by Lawdragon and Super Lawyers.\n\nDETAILS OF THE CASE: According to the lawsuit, throughout the Class Period,\ndefendants made false and/or misleading statements and/or failed to disclose\nthat: (1) Regencell was vulnerable and/or subject to market manipulation; (2)\nthe resulting volatility in the market for Regencell's ordinary shares exposed\nRegencell investors to significant financial risk; (3) all the foregoing\nsubjected Regencell to a heightened risk of regulatory and/or governmental\nscrutiny and enforcement action, as well as significant legal, monetary, and\nreputational harm; and (4) as a result, defendants' public statements were\nmaterially false and misleading at all relevant times. When the true details\nentered the market, the lawsuit claims that investors suffered damages.\n\nTo join the Regencell class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=62621 or call Phillip Kim, Esq.\ntoll-free at 866-767-3653 or email case@rosenlegal.com for information on the\nclass action.\n\nNo Class Has Been Certified. Until a class is certified, you are not\nrepresented by counsel unless you retain one. You may select counsel of your\nchoice. You may also remain an absent class member and do nothing at this\npoint. An investor's ability to share in any potential future recovery is not\ndependent upon serving as lead plaintiff.\n\nFollow us for updates on LinkedIn:\nhttps://www.linkedin.com/company/the-rosen-law-firm, on Twitter:\nhttps://twitter.com/rosen_firm or on Facebook:\nhttps://www.facebook.com/rosenlawfirm/.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\n-------------------------------\n\nContact Information:\nLaurence Rosen, Esq.\nPhillip Kim, Esq.\nThe Rosen Law Firm, P.A.\n275 Madison Avenue, 40th Floor\nNew York, NY 10016\nTel: (212) 686-1060\nToll Free: (866) 767-3653\nFax: (212) 202-3827\ncase@rosenlegal.com\nwww.rosenlegal.com\n\nSOURCE: The Rosen Law Firm, P.A.\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/rosen-global-investor-counsel-encourages-regencell-bioscience-ho-1162285)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nACSBhwhja","title":"ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGC","author":"ACCESSWIRE","ticker":"RGC","created":"2026-04-29T01:23:00.980Z","tickers":["RGC"],"exchange":"NASDAQ","article_body":"NEW YORK, NY / ACCESS Newswire (https://www.accessnewswire.com/) / April 28,\n2026 / The Rosen Law Firm, P.A.\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces a class\naction lawsuit on behalf of purchasers of securities of Regencell Bioscience\nHoldings Limited (NASDAQ:RGC) between October 28, 2024 and October 31, 2025,\ninclusive (the \"Class Period\"). A class action lawsuit has already been filed.\nIf you wish to serve as lead plaintiff, you must move the Court no later than\nJune 23, 2026.\n\nSO WHAT: If you purchased Regencell securities during the Class Period you may\nbe entitled to compensation without payment of any out of pocket fees or costs\nthrough a contingency fee arrangement.\n\nWHAT TO DO NEXT: To join the Regencell class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=62621 or call Phillip Kim, Esq.\ntoll-free at 866-767-3653 or email case@rosenlegal.com for information on the\nclass action. A class action lawsuit has already been filed. If you wish to\nserve as lead plaintiff, you must move the Court no later than June 23, 2026.\nA lead plaintiff is a representative party acting on behalf of other class\nmembers in directing the litigation.\n\nWHY ROSEN LAW: We encourage investors to select qualified counsel with a track\nrecord of success in leadership roles. Often, firms issuing notices do not\nhave comparable experience, resources, or any meaningful peer recognition. Be\nwise in selecting counsel. The Rosen Law Firm represents investors throughout\nthe globe, concentrating its practice in securities class actions and\nshareholder derivative litigation. Rosen Law Firm has achieved, at that time,\nthe largest ever securities class action settlement against a Chinese Company.\nRosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for\nnumber of securities class action settlements in 2017. The firm has been\nranked in the top 4 each year since 2013 and has recovered hundreds of\nmillions of dollars for investors. In 2019 alone the firm secured over $438\nmillion for investors. In 2020, founding partner Laurence Rosen was named by\nlaw360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been\nrecognized by Lawdragon and Super Lawyers.\n\nDETAILS OF THE CASE: According to the lawsuit, throughout the Class Period,\ndefendants made false and/or misleading statements and/or failed to disclose\nthat: (1) Regencell was vulnerable and/or subject to market manipulation; (2)\nthe resulting volatility in the market for Regencell's ordinary shares exposed\nRegencell investors to significant financial risk; (3) all the foregoing\nsubjected Regencell to a heightened risk of regulatory and/or governmental\nscrutiny and enforcement action, as well as significant legal, monetary, and\nreputational harm; and (4) as a result, defendants' public statements were\nmaterially false and misleading at all relevant times. When the true details\nentered the market, the lawsuit claims that investors suffered damages.\n\nTo join the Regencell class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=62621 or call Phillip Kim, Esq.\ntoll-free at 866-767-3653 or email case@rosenlegal.com for information on the\nclass action.\n\nNo Class Has Been Certified. Until a class is certified, you are not\nrepresented by counsel unless you retain one. You may select counsel of your\nchoice. You may also remain an absent class member and do nothing at this\npoint. An investor's ability to share in any potential future recovery is not\ndependent upon serving as lead plaintiff.\n\nFollow us for updates on LinkedIn:\nhttps://www.linkedin.com/company/the-rosen-law-firm, on Twitter:\nhttps://twitter.com/rosen_firm or on Facebook:\nhttps://www.facebook.com/rosenlawfirm/.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\n-------------------------------\n\nContact Information:\nLaurence Rosen, Esq.\nPhillip Kim, Esq.\nThe Rosen Law Firm, P.A.\n275 Madison Avenue, 40th Floor\nNew York, NY 10016\nTel: (212) 686-1060\nToll Free: (866) 767-3653\nFax: (212) 202-3827\ncase@rosenlegal.com\nwww.rosenlegal.com\n\nSOURCE: The Rosen Law Firm, P.A.\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/rosen-global-investor-counsel-encourages-regencell-bioscience-ho-1162285)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved."},"type":"article","timestamp":"2026-04-29T01:23:01.027122933Z","server_sent_at_ms":1777425781027},"received_at":"2026-04-29T01:23:01.079Z","source_url":"https://www.accessnewswire.com/newsroom/en/business-and-professional-services/rosen-global-investor-counsel-encourages-regencell-bioscience-ho-1162285"},"analysis":{"id":"9345","press_release_id":"12028","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":["Allegations of market manipulation","Allegations of failure to disclose regulatory and enforcement risks"],"eventType":"legal_litigation","narrative":"The Rosen Law Firm announced a class action lawsuit against Regencell Bioscience Holdings on behalf of investors who purchased securities between October 28, 2024 and October 31, 2025.\n\nThe complaint alleges that the company made false and misleading statements regarding its vulnerability to market manipulation and the associated financial risks.\n\nInvestors seeking to serve as lead plaintiff must move the Court no later than June 23, 2026.","sentiment":"bearish","agentHooks":{"shouldPost":true,"suggestedAngle":"Class action alleges RGC concealed market manipulation risks and exposure to regulatory scrutiny."},"quotedText":"Regencell was vulnerable and/or subject to market manipulation","namedEntities":{"people":[{"name":"Laurence Rosen","role":"Founding Partner"},{"name":"Phillip Kim","role":"Esq."}],"products":[],"companies":[{"name":"Regencell Bioscience Holdings Limited","ticker":"RGC","relationship":"defendant"},{"name":"The Rosen Law Firm, P.A.","relationship":"plaintiff counsel"}],"dollarAmounts":[]},"materialImpact":{"score":4,"reasoning":"New class action lawsuit alleging serious misconduct including market manipulation and failure to disclose material risks, which could lead to significant financial and reputational damage."},"tickerRelevance":{"others":[],"primary":"RGC"},"globalImportance":25,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"micro_cap","eventGravity":"class_action_litigation","sectorWeight":"biotech"}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"bearish","material_impact_score":4,"narrative":"The Rosen Law Firm announced a class action lawsuit against Regencell Bioscience Holdings on behalf of investors who purchased securities between October 28, 2024 and October 31, 2025.\n\nThe complaint alleges that the company made false and misleading statements regarding its vulnerability to market manipulation and the associated financial risks.\n\nInvestors seeking to serve as lead plaintiff must move the Court no later than June 23, 2026.","key_figures":null,"named_entities":{"people":[{"name":"Laurence Rosen","role":"Founding Partner"},{"name":"Phillip Kim","role":"Esq."}],"products":[],"companies":[{"name":"Regencell Bioscience Holdings Limited","ticker":"RGC","relationship":"defendant"},{"name":"The Rosen Law Firm, P.A.","relationship":"plaintiff counsel"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:1fc968c3ac7f7ebb","schema_hash":"sha256:1f8af1196c7db48c","created_at":"2026-04-29T01:26:03.453Z","global_importance":25,"audience_relevance":10,"importance_components":{"tickerTier":"micro_cap","eventGravity":"class_action_litigation","sectorWeight":"biotech"}},"durationMs":182352,"modelName":"glm-4.7"}}